BCRX Price Targets and Analyst Ratings NASDAQ:BCRX
BCRX Forecast. What You Should Know.
BCRX Historical Ratings and Targets
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.